Why Amylyx is pulling ALS drug Relyvrio from US market after study
Release time：2024-05-21 19:29:29 Source：Earth Enigma news portal
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
- Previous：What a blast to work at NASA. Space agency is sky
- Next：Mohammad Mokhber: Who is Iran’s acting president?
Related articles
- Adams, Reyna, Turner, Ream are US concerns ahead of Copa America
- China to Host Global Conference on Sci
- China Honors Shenzhou
- China Tops the World in Globally Important Agricultural Heritage Systems
- Six killed in a 'foiled coup' in Congo, the army says
- China Wins Artistic Swimming Team Technical at FINA Worlds
- Blueberries Enter Harvest Season in China's Guizhou
- Chinese sci
- Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
- Technologies Aid Efforts to Raise Public Awareness of Cultural Relic Restoration
- Hollywood star Shia LaBeouf is spotted on the streets of Gavin and Stacey's hometown Barry
- China Vows to Raise Average Life Expectancy
- China to Make All
- Villagers Perform Water Drum Dance in Jianhe County, SW China
- What's next for Iran after death of its president in crash?
- Professional ski instructor from New Zealand provides ski training in China
- Farmers Busy with Summer Farming Across China
- Beijing Rolls out Measures to Boost Consumption
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East
- Int'l Children's Day Celebrated Across China
Random recommendation
- Copyright © 2024 Powered by Why Amylyx is pulling ALS drug Relyvrio from US market after study ,Earth Enigma news portal sitemap